GRDN (Guardian Pharmacy Services) Retained Earnings: $80 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GRDN Guardian Pharmacy Services Inc GRDN
42 GF Score
Price $40.52
! 4 Warning Signs
View Full Analysis

What is Guardian Pharmacy Services Retained Earnings?

Guardian Pharmacy Services GRDN +0.37% 42 Retained Earnings is $80 Mil as of Mar. 2026. GuruFocus rates GRDN with a GF Score™ of 42/100. The stock has 4 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Guardian Pharmacy Services's retained earnings for the quarter that ended in Mar. 2026 was $80 Mil.

Guardian Pharmacy Services's quarterly retained earnings increased from Sep. 2025 ($45 Mil) to Dec. 2025 ($66 Mil) and increased from Dec. 2025 ($66 Mil) to Mar. 2026 ($80 Mil).

Guardian Pharmacy Services's annual retained earnings increased from Dec. 2023 ($0 Mil) to Dec. 2024 ($17 Mil) and increased from Dec. 2024 ($17 Mil) to Dec. 2025 ($66 Mil).


Guardian Pharmacy Services  (NYSE:GRDN) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Guardian Pharmacy Services Retained Earnings Historical Data

* Premium members only.

The historical data trend for Guardian Pharmacy Services's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardian Pharmacy Services Retained Earnings Chart

Guardian Pharmacy Services Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial 0.00 0.00 0.00 17.12 66.34

Guardian Pharmacy Services Quarterly Data
Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.57 35.60 45.42 66.34 79.64
GRDN
42GF Score
Guardian Pharmacy Services Inc GRDN
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardian Pharmacy Services Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $80 Mil mean?
Guardian Pharmacy Services (GRDN) has a Retained Earnings of $80 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Guardian Pharmacy Services and its competitors.
Is Guardian Pharmacy Services' Retained Earnings too high?
Guardian Pharmacy Services' current Retained Earnings is $80 Mil. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' Retained Earnings compare to ACHC and ASTH?
Guardian Pharmacy Services' Retained Earnings of $80 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Healthcare Providers & Services company?
A good Retained Earnings depends on the Healthcare Providers & Services industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Guardian Pharmacy Services and its competitors. Guardian Pharmacy Services's current Retained Earnings is $80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current Retained Earnings of $80 Mil. The current Retained Earnings is $80 Mil. Guardian Pharmacy Services' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current Retained Earnings is $80 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guardian Pharmacy Services Business Description

Address 300 Galleria Parkway SE, Suite 800, Atlanta, GA, USA, 30339
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score

Get the complete analysis for GRDN

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.52
Price